Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2
Open Access
- 1 March 1999
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 103 (5) , 683-689
- https://doi.org/10.1172/jci4445
Abstract
Deficiency of 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) in humans leads to the syndrome of apparent mineralocorticoid excess (SAME), in which cortisol illicitly occupies mineralocorticoid receptors, causing sodium retention, hypokalemia, and hypertension. However, the disorder is usually incompletely corrected by suppression of cortisol, suggesting additional and irreversible changes, perhaps in the kidney. To examine this further, we produced mice with targeted disruption of the 11β-HSD2 gene. Homozygous mutant mice (11β-HSD2–/–) appear normal at birth, but ∼50% show motor weakness and die within 48 hours. Both male and female survivors are fertile but exhibit hypokalemia, hypotonic polyuria, and apparent mineralocorticoid activity of corticosterone. Young adult 11β-HSD2–/– mice are markedly hypertensive, with a mean arterial blood pressure of 146 ± 2 mmHg, compared with 121 ± 2 mmHg in wild-type controls and 114 ± 4 mmHg in heterozygotes. The epithelium of the distal tubule of the nephron shows striking hypertrophy and hyperplasia. These histological changes do not readily reverse with mineralocorticoid receptor antagonism in adulthood. Thus, 11β-HSD2–/– mice demonstrate the major features of SAME, providing a unique rodent model to study the molecular mechanisms of kidney resetting leading to hypertension. J. Clin. Invest. 103:683–689 (1999)Keywords
This publication has 36 references indexed in Scilit:
- Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type IIINature Genetics, 1997
- Mutations in the 11β-Hydroxysteroid Dehydrogenase Type II Enzyme Associated with Hypertension and Possibly StillbirthClinical and Experimental Hypertension, 1997
- Targeted Inactivation of the Ren-2 Gene in MiceHypertension, 1996
- Inhibition of 11β-Hydroxysteroid Dehydrogenase in Pregnant Rats and the Programming of Blood Pressure in the OffspringHypertension, 1996
- Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenaseNature Genetics, 1995
- Regulation of 11β-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidneyJournal of Endocrinology, 1993
- Blood Pressure Control—Special Role of the Kidneys and Body FluidsScience, 1991
- LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTORThe Lancet, 1988
- Renal Tubular Antigens in Regenarative Epithelium and Renal CarcinomaBritish Journal of Urology, 1987
- On the Mechanism of Polyuria in Potassium DepletionJournal of Clinical Investigation, 1977